Balaji, M. S., and M. Girish. “A Study of Utility of Delta IGG As a Prognostic Marker in Guillain Barre Syndrome After IV Immunoglobulin Treatment”. International Journal of Health Sciences, vol. 6, no. S6, July 2022, pp. 3361-74, doi:10.53730/ijhs.v6nS6.10406.